Poland· PL-100449850
Netaxen
A dexamethason mit antiinfektiva product containing netilmicinum + dexamethasonum, registered in Poland by SIFI S.p.A.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Dexamethason mit antiinfektiva is registered in 11 of 19 countries.
Countries holding a registration under ATC S01CA01 (dexamethason mit antiinfektiva), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Dexamethason mit antiinfektiva · ATC S01CA01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Netilmicinum + Dexamethasonum
- Manufacturer
- SIFI S.p.A.
- Country
- Poland (PL)
- ATC code
- S01CA01
- ATC class
- Dexamethason mit Antiinfektiva
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991479251
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dexamethason mit antiinfektiva in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainNETDEX 3 MG/ML + 1 MG/ML COLIRIO EN SOLUCIONSifi S.P.A.
- FranceNETAXEN 1 mg/3 mg par ml, collyre en solutionSIFI (ITALIE)
- United KingdomNetildex 3mg/ml / 1mg/ml eye dropsNordic Pharma Ltd
- GermanyNetildexSifi S.P.A.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Germany · Netildex
- Italy · Galminor, Ipokima
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/087e3be6-8a8c-46ac-ac31-f0b3fcf762fa GET /v1/drugs/087e3be6-8a8c-46ac-ac31-f0b3fcf762fa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do oczu, roztwór",
"source": "urpl",
"strength": "3 mg/ml + 1 mg/ml",
"packaging": "05909991479251 ¦ Rp ¦ 144334\n1 butelka 5 ml",
"substance": "Netilmicini sulfas 4.55 mg/ml + Dexamethasoni Natrii phosphas 1.32 mg/ml",
"common_name": "Netilmicinum + Dexamethasonum",
"pl_product_id": "100449850",
"pozwolenie_nr": "26991",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about dexamethason mit antiinfektiva.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.